Perspectum
Perspectum develops solutions for major unmet needs in diagnostic medicine in multiple internal organs.
Perspectum has raised €85M across 3 funding rounds from 4 investors, most recently a Series C round in Mar 2023. Based in Oxford, UK; founded 2011; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€85M
€85,098,064
Funding rounds
3
Investors
4
distinct backers
Active since
2020-04
latest 2023-03
Funding by year
EUR raised per yearPerspectum — funding by year — interactive chart.
Data table
| Perspectum — funding by year | |
|---|---|
| 2020 | €33M |
| 2023 | €52M |
Signals
High confidenceRaise-next likelihood9
base rate 50% for Series C
- ▼ Past typical raise window
- ▼ Down/flat last round
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-15 | Series C | €18M | Oppenheimer & Co. | View deal → |
| 2023-01-05 | Series C | €34M | Oppenheimer & Co. | View deal → |
| 2020-04-14 | Other | €33M | BlueCross BlueShield Venture Partners,HealthQuest Capital | View deal → |
Related news
- Perspectum Closes $19M Second Close of Series C Fundingfinsmes.com · 2023-03
- Perspectum Closes $36M First Close of Series C Fundingfinsmes.com · 2023-01
- finsmes.com
Similar companies
same sector or countryGlobal coverage: FundingData